Skip to main content
Premium Trial:

Request an Annual Quote

NIAMS to Fund Small Business Grants for Multiplex Assay Projects

NEW YORK (GenomeWeb News) – The National Institute of Arthritis and Musculoskeletal and Skin Diseases aims to fund small businesses developing new multiplex diagnostic technologies that target biomarkers for a range of diseases.

NIAMS plans to provide Small Business Innovation Research grants of $150,000 for phase I projects and $1 million for phase II efforts to businesses developing multiplex tools for measuring multiple protein, DNA, or RNA-based biomarkers that can be detected in small volumes of fluid or biopsies.

Many of the diseases in the NIAMS portfolio, such as osteoarthritis, rheumatoid arthritis, psoriasis, psoriatic arthritis, and others, are chronic, complex, and progress very slowly. The slow development of these disorders may offer many circulating biomarkers that could be used in early diagnosis, but the biological resources to evaluate those markers are in short supply, according to NIAMS.

Single marker assays have been used for a variety of diseases but they offer limited benefits, and few have become useful for routine clinical practice, NIAMS stated in a request for applications this week.

The institute sees multiplex arrays that measure multiple protein and genetic biomarkers as more useful for screening for disease, assessing disease risk, severity, and prognosis, and potentially saving time, cost, and sample consumption. Many disorders may require a panel of biomarkers to characterize the stage or nature of a disease, so NIAMS sees a need for high-throughput multiplex assays that can produce accurate quantitative data.

Today, few assays for multiple biomarkers are available in the multiplex format and allow high throughput of a large number of specimens that are required for proof-of-concept studies, and most of those lack sensitivity and reproducibility and have high variability, the institute said.

NIAMS said this program will fund development of multiplex assay platforms that rise above those limitations, can quantify multiple biomarker candidates in small quantities of biospecimens, and can incorporate new candidate biomarkers as they become available.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.